PARVOVAX
PARVOVAX
Authorised
- Porcine parvovirus, strain K22, Inactivated
Product identification
Medicine name:
PARVOVAX
Active substance:
- Porcine parvovirus, strain K22, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine parvovirus, strain K22, Inactivated2.00/haemagglutinating units1.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Type 1 glass bottle;Nitrile elastomer closure; Aluminium cap; 25-dose bottle, 1-bottle package.
- Type 1 glass bottle;Nitrile elastomer closure; Aluminium cap; 5-dose bottle, 1-bottle package.
- Type 1 glass bottle;Nitrile elastomer closure; Aluminium cap; 1-dose bottle, 10-bottle package.
- Type 1 glass bottle;Nitrile elastomer closure; Aluminium cap; 1-dose bottle, 1-bottle package.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Merial
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10815/053/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
